ARNA Related Analyst Ratings
-
Leerink Swann Downgrades Arena Pharmaceuticals (ARNA) to Market Perform
-
Rodman & Renshaw Cuts Arena Pharma (ARNA) to Underperform
-
Arena Pharmaceuticals (ARNA) Falls As Results Fall Short Against Others
-
Rodman and Renshaw Downgrades Arena Pharma (ARNA) to Market Perform
-
Rodman & Renshaw Initiates Coverage of Arena Pharmaceuticals (ARNA) with a Market Outperform
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)
-
Needham Downgrades Arena Pharmaceuticals (ARNA) to Hold
-
Canaccord Adams Downgrades Arena Pharmaceuticals (ARNA) to Sell; Drops Price Target on High Clinical Risks
-
UBS Downgrades Arena Pharmaceuticals (ARNA) to Neutral
-
BofA Upgrades Arena Pharmaceuticals (ARNA) to Buy
-
Soleil Securities Reiterates Buy on Arena Pharmaceuticals (ARNA)
-
J.P. Morgan Initiates Coverage on Arena Pharmaceuticals (ARNA) with a Neutral
-
Soleil Securities Group Lowers Price Target on Arena Pharmaceuticals (ARNA) to $16
-
Wachovia Starts Arena Pharmaceuticals (ARNA) at Market Perform
-
ThinkEquity Starts Arena Pharma (ARNA) at Buy
-
Bank of America Starts Arena Pharmaceuticals (ARNA) at Neutral
-
AG Edwards upgrades Arena Pharma (ARNA) to Buy
-
Prudential Starts Arena Pharma (ARNA) at Overweight
-
AG Edwards downgrades Arena Pharma (ARNA) to Hold
-
Jim Cramer Makes Positive Comments on Arena Pharmaceuticals (ARNA)
-
AG Edwards Starts Arena Pharma (ARNA) at Buy
-
Needham Analyst Discusses Partnering Opportunities in Biotech
-
UBS Starts Arena Pharmaceuticals Inc. (ARNA) with a Buy
-
Lehman Brothers Starts Arena Pharma (ARNA) at Equal Weight
-
Jim Cramer Makes Positive Comments on Dow Chemical (DOW) and Arena Pharmac (ARNA)
-
Needham raises its price target on ARNA
-
Merriman Curhan Starts ARNA at Buy
-
Thomas Weisel Partners Initiates ARNA
-
Morgan Joseph Initiates ARNA
-
CIBC upgrades ARNA to Outperform
-
Needham Starts ARNA at Buy
-
Piper Jaffray Started ARNA at Outperform; $9 trgt
Back to ARNA Stock Lookup
